We are looking for children 2–17 years old to join a CD trial to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or moderate to severe Crohn’s disease (including associated symptoms such as abdominal cramping, weight loss, diarrhea, frequent fevers and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the GI clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
